Oncimmune Net Receivables vs Accounts Payable Analysis

ONC Stock   14.75  0.05  0.34%   
Oncimmune Holdings financial indicator trend analysis is much more than just breaking down Oncimmune Holdings plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncimmune Holdings plc is a good investment. Please check the relationship between Oncimmune Holdings Net Receivables and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Net Receivables vs Accounts Payable

Net Receivables vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Oncimmune Holdings plc Net Receivables account and Accounts Payable. At this time, the significance of the direction appears to have very week relationship.
The correlation between Oncimmune Holdings' Net Receivables and Accounts Payable is 0.22. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Oncimmune Holdings plc, assuming nothing else is changed. The correlation between historical values of Oncimmune Holdings' Net Receivables and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Oncimmune Holdings plc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Receivables i.e., Oncimmune Holdings' Net Receivables and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.22
Relationship DirectionPositive 
Relationship StrengthVery Weak

Net Receivables

Accounts Payable

An accounting item on the balance sheet that represents Oncimmune Holdings obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Oncimmune Holdings plc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Oncimmune Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncimmune Holdings plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Tax Provision is expected to grow to about 269.3 K, whereas Selling General Administrative is forecasted to decline to about 474.1 K.
 2021 2022 2023 2024 (projected)
Interest Expense943K2.0M2.3M2.4M
Depreciation And Amortization197K265K304.8K256.3K

Oncimmune Holdings fundamental ratios Correlations

0.740.070.680.420.78-0.04-0.830.590.640.850.640.750.460.380.410.70.760.950.760.360.510.450.140.140.7
0.740.190.630.080.740.25-0.860.580.270.810.270.620.520.470.720.70.730.590.650.610.280.5-0.130.450.48
0.070.19-0.08-0.260.270.330.0-0.43-0.140.22-0.14-0.030.64-0.480.160.270.31-0.04-0.010.4-0.29-0.3-0.350.730.61
0.680.63-0.08-0.230.810.5-0.790.9-0.010.83-0.010.30.430.850.680.890.760.490.350.270.280.92-0.320.140.55
0.420.08-0.26-0.23-0.14-0.91-0.14-0.050.91-0.040.910.41-0.43-0.27-0.46-0.35-0.160.630.39-0.220.45-0.290.89-0.38-0.05
0.780.740.270.81-0.140.5-0.870.640.110.950.110.590.70.530.790.910.980.570.620.540.420.67-0.360.470.73
-0.040.250.330.5-0.910.5-0.220.29-0.740.43-0.74-0.060.690.440.710.670.53-0.31-0.050.47-0.210.49-0.940.550.35
-0.83-0.860.0-0.79-0.14-0.87-0.22-0.8-0.32-0.89-0.32-0.66-0.4-0.6-0.67-0.75-0.81-0.67-0.69-0.39-0.47-0.680.02-0.26-0.5
0.590.58-0.430.9-0.050.640.29-0.80.060.680.060.340.10.910.570.670.570.450.390.140.40.92-0.08-0.10.22
0.640.27-0.14-0.010.910.11-0.74-0.320.060.161.00.56-0.12-0.16-0.24-0.060.080.840.52-0.130.4-0.180.76-0.350.17
0.850.810.220.83-0.040.950.43-0.890.680.160.160.640.670.540.710.910.940.630.680.60.440.67-0.320.50.77
0.640.27-0.14-0.010.910.11-0.74-0.320.061.00.160.56-0.12-0.16-0.24-0.060.080.840.52-0.130.4-0.180.76-0.350.17
0.750.62-0.030.30.410.59-0.06-0.660.340.560.640.560.440.190.410.420.640.70.960.580.690.150.050.150.34
0.460.520.640.43-0.430.70.69-0.40.1-0.120.67-0.120.440.110.640.780.760.270.420.7-0.030.18-0.690.660.76
0.380.47-0.480.85-0.270.530.44-0.60.91-0.160.54-0.160.190.110.660.620.490.230.230.180.340.95-0.3-0.110.08
0.410.720.160.68-0.460.790.71-0.670.57-0.240.71-0.240.410.640.660.790.810.180.450.650.260.67-0.610.460.35
0.70.70.270.89-0.350.910.67-0.750.67-0.060.91-0.060.420.780.620.790.910.470.470.540.170.71-0.540.440.76
0.760.730.310.76-0.160.980.53-0.810.570.080.940.080.640.760.490.810.910.540.690.660.450.6-0.430.520.74
0.950.59-0.040.490.630.57-0.31-0.670.450.840.630.840.70.270.230.180.470.540.70.170.490.260.39-0.10.55
0.760.65-0.010.350.390.62-0.05-0.690.390.520.680.520.960.420.230.450.470.690.70.640.690.210.050.210.39
0.360.610.40.27-0.220.540.47-0.390.14-0.130.6-0.130.580.70.180.650.540.660.170.640.340.16-0.560.640.47
0.510.28-0.290.280.450.42-0.21-0.470.40.40.440.40.69-0.030.340.260.170.450.490.690.340.340.16-0.120.11
0.450.5-0.30.92-0.290.670.49-0.680.92-0.180.67-0.180.150.180.950.670.710.60.260.210.160.34-0.320.060.26
0.14-0.13-0.35-0.320.89-0.36-0.940.02-0.080.76-0.320.760.05-0.69-0.3-0.61-0.54-0.430.390.05-0.560.16-0.32-0.55-0.31
0.140.450.730.14-0.380.470.55-0.26-0.1-0.350.5-0.350.150.66-0.110.460.440.52-0.10.210.64-0.120.06-0.550.54
0.70.480.610.55-0.050.730.35-0.50.220.170.770.170.340.760.080.350.760.740.550.390.470.110.26-0.310.54
Click cells to compare fundamentals

Oncimmune Holdings Account Relationship Matchups

Oncimmune Holdings fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.3M24.3M17.3M8.4M9.7M10.2M
Other Current Liab1.0M1.2M6K722K830.3K634.2K
Total Current Liabilities3.5M9.8M15.1M1.4M1.6M1.6M
Total Stockholder Equity(194K)5.2M(2.7M)657K755.6K717.8K
Property Plant And Equipment Net1.4M1.6M1.5M591K679.7K617.1K
Net Debt4.0M837K8.2M2.1M2.4M2.5M
Retained Earnings(65.5M)(70.1M)(79.6M)(42.5M)(38.3M)(40.2M)
Accounts Payable420K768K2.0M172K197.8K187.9K
Cash4.2M8.6M2.5M3.2M3.7M5.3M
Non Current Assets Total4.1M8.2M7.3M2.9M3.3M2.6M
Cash And Short Term Investments4.2M8.6M2.5M3.2M3.7M5.3M
Liabilities And Stockholders Equity10.3M24.3M17.3M8.4M9.7M10.2M
Non Current Liabilities Total7.0M9.3M4.9M6.4M7.3M7.7M
Other Current Assets23K427K7.0M199K228.9K217.4K
Other Stockholder Equity64.6M38.6M76.2M42.7M49.1M39.1M
Total Liab10.5M19.1M20.0M7.8M8.9M7.1M
Property Plant And Equipment Gross1.4M1.6M1.5M870K1.0M642.7K
Total Current Assets6.2M16.1M10.0M5.6M6.4M7.5M
Accumulated Other Comprehensive Income(967K)4.2M(42K)(223K)(256.5K)(269.3K)
Common Stock635K691K695K741K852.2K463.7K
Common Stock Shares Outstanding63.3M64.6M64.5M72.5M83.4M62.2M
Inventory174K143K413K235K270.3K193.7K
Net Tangible Assets5.4M(2.6M)(467K)(7.5M)(6.8M)(6.4M)
Net Receivables1.8M6.9M1.7M1.9M2.2M1.6M
Property Plant Equipment422K1.4M1.6M1.5M1.8M1.9M
Other Assets356K937K927K1.01.151.09
Deferred Long Term Liab671K512K356K196K225.4K379.3K
Intangible Assets1.1M4.1M3.2M483K555.5K527.7K
Non Currrent Assets Other872K3.4M(937K)483.0K434.7K664.3K
Net Invested Capital7.1M13.7M7.2M5.8M5.2M6.9M
Net Working Capital2.8M6.3M(5.1M)4.1M3.7M3.4M
Capital Stock635K691K695K741K852.2K746.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Oncimmune Stock

Balance Sheet is a snapshot of the financial position of Oncimmune Holdings plc at a specified time, usually calculated after every quarter, six months, or one year. Oncimmune Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Oncimmune Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Oncimmune currently owns. An asset can also be divided into two categories, current and non-current.